Study Name,SiteGroupName(CountryName),SiteNumber,SubjectName,Overall Subject Status,Visit Level Subject Status,FolderName,FormName,Visit date,No. #Days Page Missing
Study 24,AUS,Site 28,Subject 107,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 28,Subject 107,On Trial,,Study Treatment,Form 2,,
Study 24,AUS,Site 28,Subject 107,On Trial,,Study Treatment,Form 3,,
Study 24,AUS,Site 28,Subject 108,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 28,Subject 108,On Trial,Subject continuing,Screening,Form 5,18 SEP 2025,57
Study 24,AUS,Site 28,Subject 108,On Trial,,Study Treatment,Form 6,,
Study 24,AUS,Site 28,Subject 108,On Trial,,Study Treatment,Form 3,,
Study 24,AUS,Site 28,Subject 2233,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 28,Subject 2233,On Trial,,Study Treatment,Form 6,,
Study 24,AUS,Site 28,Subject 2233,On Trial,,Study Treatment,Form 2,,
Study 24,AUS,Site 28,Subject 2234,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 28,Subject 2234,On Trial,,Study Treatment,Form 6,,
Study 24,AUS,Site 28,Subject 2234,On Trial,,Study Treatment,Form 2,,
Study 24,AUS,Site 28,Subject 2234,On Trial,,Study Treatment,Form 7,,
Study 24,AUS,Site 259,Subject 2236,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 259,Subject 4990,On Trial,,Disposition,Form 1,,
Study 24,AUS,Site 259,Subject 4990,On Trial,Subject continuing,Screening,Form 8,01 OCT 2025,44
Study 24,AUS,Site 259,Subject 4990,On Trial,Subject continuing,Screening,Form 9,01 OCT 2025,44
Study 24,AUS,Site 259,Subject 4990,On Trial,,Study Treatment,Form 6,,
Study 24,AUS,Site 259,Subject 4990,On Trial,,Study Treatment,Form 2,,
Study 24,AUS,Site 259,Subject 4990,On Trial,,Study Treatment,Form 3,,
Study 24,AUS,Site 259,Subject 4990,On Trial,,Study Treatment,Form 10,,
Study 24,AUS,Site 259,Subject 4991,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 952,Subject 13635,On Trial,Subject continuing,Screening,Form 11,24 SEP 2025,51
Study 24,CAN,Site 952,Subject 13635,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 952,Subject 13637,On Trial,Subject continuing,Screening,Form 12,22 OCT 2025,23
Study 24,CAN,Site 952,Subject 13637,On Trial,Subject continuing,Screening,Form 13,22 OCT 2025,23
Study 24,CAN,Site 952,Subject 13637,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 952,Subject 13637,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 952,Subject 13637,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 952,Subject 13637,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 952,Subject 13638,Screening,,Screening,Form 14,28 OCT 2025,17
Study 24,CAN,Site 952,Subject 13638,Screening,,Screening,Form 15,28 OCT 2025,17
Study 24,CAN,Site 952,Subject 13639,On Trial,Subject continuing,Screening,Form 12,30 OCT 2025,15
Study 24,CAN,Site 952,Subject 13639,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 952,Subject 13639,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 952,Subject 13639,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 952,Subject 13639,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 953,Subject 13651,On Trial,Subject continuing,Screening,Form 12,29 AUG 2025,77
Study 24,CAN,Site 953,Subject 13652,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,CAN,Site 953,Subject 13653,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,CAN,Site 953,Subject 13655,On Trial,Subject continuing,Screening,Form 12,01 OCT 2025,44
Study 24,CAN,Site 953,Subject 13656,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,28 OCT 2025,17
Study 24,CAN,Site 953,Subject 13656,On Trial,Subject continuing,Screening,Form 12,06 OCT 2025,39
Study 24,CAN,Site 953,Subject 13656,On Trial,Subject continuing,Screening,Form 17,06 OCT 2025,39
Study 24,CAN,Site 953,Subject 47750,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,27 OCT 2025,18
Study 24,CAN,Site 953,Subject 47750,On Trial,Subject continuing,Screening,Form 12,08 OCT 2025,37
Study 24,CAN,Site 953,Subject 47751,On Trial,Subject continuing,Screening,Form 12,09 OCT 2025,36
Study 24,CAN,Site 953,Subject 47751,On Trial,,Study Treatment,Form 7,,
Study 24,CAN,Site 953,Subject 47752,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,20 OCT 2025,25
Study 24,CAN,Site 953,Subject 47752,On Trial,Subject continuing,Screening,Form 12,15 OCT 2025,30
Study 24,CAN,Site 953,Subject 47753,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,29 OCT 2025,16
Study 24,CAN,Site 953,Subject 47753,On Trial,Subject continuing,Screening,Form 12,21 OCT 2025,24
Study 24,CAN,Site 953,Subject 47753,On Trial,Subject continuing,Screening,Form 17,21 OCT 2025,24
Study 24,CAN,Site 953,Subject 47753,On Trial,,Study Treatment,Form 18,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Study Treatment,Form 18,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 954,Subject 13658,On Trial,,Study Treatment,Form 7,,
Study 24,CAN,Site 955,Subject 13668,On Trial,Subject continuing,Screening,Form 17,22 AUG 2025,84
Study 24,CAN,Site 955,Subject 13668,On Trial,Subject continuing,Screening,Form 16,22 AUG 2025,84
Study 24,CAN,Site 955,Subject 38951,On Trial,Subject continuing,Screening,Form 16,18 SEP 2025,57
Study 24,CAN,Site 955,Subject 38952,On Trial,Subject continuing,Screening,Form 12,19 SEP 2025,56
Study 24,CAN,Site 955,Subject 47756,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 955,Subject 47756,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 955,Subject 47756,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 955,Subject 47757,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 955,Subject 47757,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 955,Subject 47757,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 955,Subject 47757,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 955,Subject 47757,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 955,Subject 47759,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 955,Subject 47759,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 955,Subject 47759,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 955,Subject 47759,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 955,Subject 47760,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 955,Subject 47761,Screening,Subject continuing,Screening,Form 14,29 OCT 2025,16
Study 24,CAN,Site 955,Subject 47762,Screening,Subject continuing,Screening,Form 14,13 NOV 2025,1
Study 24,CAN,Site 963,Subject 13826,On Trial,Subject continuing,Cycle 4 Day 1,Form 16,21 OCT 2025,24
Study 24,CAN,Site 963,Subject 13829,On Trial,Subject continuing,Screening,Form 13,14 AUG 2025,92
Study 24,CAN,Site 963,Subject 13829,On Trial,Subject continuing,Screening,Form 19,14 AUG 2025,92
Study 24,CAN,Site 963,Subject 13829,On Trial,Subject continuing,Screening,Form 20,14 AUG 2025,92
Study 24,CAN,Site 963,Subject 13835,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 21,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 12,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 22,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 23,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 19,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 24,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 8,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 9,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 25,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,Subject continuing,Screening,Form 16,17 SEP 2025,58
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 18,,
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 7,,
Study 24,CAN,Site 963,Subject 13835,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 963,Subject 13839,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 963,Subject 13839,On Trial,Subject continuing,Screening,Form 21,16 OCT 2025,29
Study 24,CAN,Site 963,Subject 13839,On Trial,Subject continuing,Screening,Form 12,16 OCT 2025,29
Study 24,CAN,Site 963,Subject 13839,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 963,Subject 13839,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 963,Subject 13839,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 963,Subject 13839,On Trial,,Study Treatment,Form 7,,
Study 24,CAN,Site 963,Subject 13839,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 963,Subject 39017,On Trial,Subject continuing,Screening,Form 5,16 OCT 2025,29
Study 24,CAN,Site 963,Subject 39017,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 963,Subject 39017,On Trial,,Study Treatment,Form 10,,
Study 24,CAN,Site 963,Subject 39018,On Trial,,Disposition,Form 1,,
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 21,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 12,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 11,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 8,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 9,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 25,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,Subject continuing,Screening,Form 16,4 NOV 2025,10
Study 24,CAN,Site 963,Subject 39018,On Trial,,Study Treatment,Form 6,,
Study 24,CAN,Site 963,Subject 39018,On Trial,,Study Treatment,Form 2,,
Study 24,CAN,Site 963,Subject 39018,On Trial,,Study Treatment,Form 3,,
Study 24,CAN,Site 963,Subject 39018,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 503,Subject 3706,Screening,,Screening,Form 15,31 OCT 2025,14
Study 24,CHN,Site 503,Subject 3707,Screening,,Screening,Form 14,3 NOV 2025,11
Study 24,CHN,Site 503,Subject 3707,Screening,,Screening,Form 15,3 NOV 2025,11
Study 24,CHN,Site 503,Subject 3708,Screening,,Screening,Form 14,6 NOV 2025,8
Study 24,CHN,Site 503,Subject 3708,Screening,,Screening,Form 15,6 NOV 2025,8
Study 24,CHN,Site 503,Subject 3709,Screening,,Screening,Form 14,10 NOV 2025,4
Study 24,CHN,Site 503,Subject 3709,Screening,,Screening,Form 15,10 NOV 2025,4
Study 24,CHN,Site 507,Subject 3727,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 507,Subject 3728,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 420,Subject 6459,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 420,Subject 6459,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 420,Subject 6459,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 420,Subject 6459,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 420,Subject 47696,Screening,,Screening,Form 14,31 OCT 2025,14
Study 24,CHN,Site 420,Subject 47696,Screening,,Screening,Form 15,31 OCT 2025,14
Study 24,CHN,Site 421,Subject 3235,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 421,Subject 3235,On Trial,Subject continuing,Screening,Form 5,24 OCT 2025,21
Study 24,CHN,Site 421,Subject 3235,On Trial,Subject continuing,Screening,Form 8,24 OCT 2025,21
Study 24,CHN,Site 421,Subject 3235,On Trial,Subject continuing,Screening,Form 9,24 OCT 2025,21
Study 24,CHN,Site 421,Subject 3235,On Trial,Subject continuing,Screening,Form 25,24 OCT 2025,21
Study 24,CHN,Site 421,Subject 3235,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 421,Subject 3235,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 421,Subject 3235,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 421,Subject 3235,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 421,Subject 3236,On Trial,Subject continuing,Screening,Form 5,21 OCT 2025,24
Study 24,CHN,Site 421,Subject 3236,On Trial,Subject continuing,Screening,Form 8,21 OCT 2025,24
Study 24,CHN,Site 421,Subject 3236,On Trial,Subject continuing,Screening,Form 9,21 OCT 2025,24
Study 24,CHN,Site 421,Subject 3236,On Trial,Subject continuing,Screening,Form 25,21 OCT 2025,24
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 421,Subject 3236,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 423,Subject 3247,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 423,Subject 6489,On Trial,Subject continuing,Screening,Form 25,20 OCT 2025,25
Study 24,CHN,Site 423,Subject 6490,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 423,Subject 6490,On Trial,Subject continuing,Screening,Form 9,24 OCT 2025,21
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 423,Subject 6490,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 423,Subject 6491,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 423,Subject 6491,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 423,Subject 6491,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 423,Subject 6491,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 423,Subject 6491,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 425,Subject 3256,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 425,Subject 3256,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 425,Subject 3256,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 425,Subject 3256,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 2183,Subject 47702,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 2183,Subject 47702,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 2184,Subject 47703,On Trial,Subject continuing,Screening,Form 12,23 SEP 2025,52
Study 24,CHN,Site 2184,Subject 47707,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2184,Subject 47707,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 2184,Subject 47708,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2184,Subject 47709,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2184,Subject 47712,Screening,Subject continuing,Screening,Form 14,06 NOV 2025,8
Study 24,CHN,Site 426,Subject 3257,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 426,Subject 47713,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 426,Subject 47714,On Trial,Subject continuing,Screening,Form 5,29 OCT 2025,16
Study 24,CHN,Site 426,Subject 47714,On Trial,Subject continuing,Screening,Form 16,29 OCT 2025,16
Study 24,CHN,Site 426,Subject 47714,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 426,Subject 47714,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 426,Subject 47714,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 426,Subject 47715,Screening,Subject continuing,Screening,Form 14,3 NOV 2025,11
Study 24,CHN,Site 2185,Subject 47717,On Trial,Subject continuing,Screening,Form 9,04 SEP 2025,71
Study 24,CHN,Site 2185,Subject 47718,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 2185,Subject 47720,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 2185,Subject 47720,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 2185,Subject 47720,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 2185,Subject 47720,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2185,Subject 47720,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Disposition,Form 1,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,Subject continuing,Screening,Form 9,30 OCT 2025,15
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 6,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 2,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 3,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 7,,
Study 24,CHN,Site 2185,Subject 47721,On Trial,,Study Treatment,Form 10,,
Study 24,CHN,Site 2186,Subject 47726,On Trial,,Study Treatment,Form 18,,
Study 24,CHN,Site 2186,Subject 47727,On Trial,Subject continuing,Screening,Form 16,25 SEP 2025,50
Study 24,DEU,Site 520,Subject 3767,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 520,Subject 3767,On Trial,Subject continuing,Screening,Form 12,6 OCT 2025,39
Study 24,DEU,Site 520,Subject 3767,On Trial,Subject continuing,Screening,Form 23,6 OCT 2025,39
Study 24,DEU,Site 520,Subject 3767,On Trial,Subject continuing,Screening,Form 19,6 OCT 2025,39
Study 24,DEU,Site 520,Subject 3767,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 520,Subject 3767,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 520,Subject 3767,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 520,Subject 3767,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 520,Subject 3768,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 520,Subject 3768,On Trial,Subject continuing,Screening,Form 12,23 OCT 2025,22
Study 24,DEU,Site 520,Subject 3768,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 520,Subject 3768,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 520,Subject 3768,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 520,Subject 3768,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 520,Subject 3769,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 520,Subject 3769,On Trial,Subject continuing,Screening,Form 12,20 OCT 2025,25
Study 24,DEU,Site 520,Subject 3769,On Trial,Subject continuing,Screening,Form 17,20 OCT 2025,25
Study 24,DEU,Site 520,Subject 8868,Screening,Subject continuing,Screening,Form 14,10 NOV 2025,4
Study 24,DEU,Site 521,Subject 3773,On Trial,Subject continuing,Screening,Form 12,1 OCT 2025,44
Study 24,DEU,Site 521,Subject 8892,On Trial,Subject continuing,Screening,Form 12,8 OCT 2025,37
Study 24,DEU,Site 521,Subject 8893,On Trial,Subject continuing,Screening,Form 12,27 OCT 2025,18
Study 24,DEU,Site 521,Subject 8893,On Trial,Subject continuing,Screening,Form 9,27 OCT 2025,18
Study 24,DEU,Site 522,Subject 3774,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 522,Subject 3774,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 522,Subject 3774,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 522,Subject 3774,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 522,Subject 8927,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 522,Subject 8927,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 522,Subject 8927,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 522,Subject 8928,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 522,Subject 8928,On Trial,Subject continuing,Screening,Form 17,26 SEP 2025,49
Study 24,DEU,Site 522,Subject 8928,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 522,Subject 8928,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 875,Subject 8977,On Trial,Subject continuing,Screening,Form 20,22 SEP 2025,53
Study 24,DEU,Site 875,Subject 8978,On Trial,Subject continuing,Screening,Form 21,22 SEP 2025,53
Study 24,DEU,Site 875,Subject 8980,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 875,Subject 8981,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,13 OCT 2025,32
Study 24,DEU,Site 875,Subject 8982,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,23 OCT 2025,22
Study 24,DEU,Site 875,Subject 8982,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 875,Subject 8982,On Trial,Subject continuing,Screening,Form 21,09 OCT 2025,36
Study 24,DEU,Site 875,Subject 8983,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 875,Subject 8983,On Trial,Subject continuing,Screening,Form 21,14 OCT 2025,31
Study 24,DEU,Site 875,Subject 8983,On Trial,Subject continuing,Screening,Form 12,14 OCT 2025,31
Study 24,DEU,Site 875,Subject 8985,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 875,Subject 8986,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 875,Subject 8986,On Trial,Subject continuing,Screening,Form 21,29 OCT 2025,16
Study 24,DEU,Site 875,Subject 8986,On Trial,Subject continuing,Screening,Form 17,29 OCT 2025,16
Study 24,DEU,Site 876,Subject 8989,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 876,Subject 8989,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 876,Subject 8990,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 876,Subject 8990,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 876,Subject 8991,On Trial,Subject continuing,Screening,Form 9,16 OCT 2025,29
Study 24,DEU,Site 876,Subject 8991,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 876,Subject 8991,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 876,Subject 8993,On Trial,Subject continuing,Screening,Form 9,23 OCT 2025,22
Study 24,DEU,Site 876,Subject 8993,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 876,Subject 8993,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 876,Subject 8993,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 876,Subject 8993,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 879,Subject 9113,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 879,Subject 9113,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 880,Subject 9117,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,DEU,Site 880,Subject 9117,On Trial,Subject continuing,Screening,Form 22,29 SEP 2025,46
Study 24,DEU,Site 880,Subject 9117,On Trial,Subject continuing,Screening,Form 17,29 SEP 2025,46
Study 24,DEU,Site 880,Subject 9117,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 880,Subject 9117,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 21,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 12,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 5,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 22,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 13,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 23,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 17,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 19,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 24,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 8,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 9,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 25,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,Subject continuing,Screening,Form 16,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9118,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 880,Subject 9118,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 880,Subject 9119,On Trial,,Concomitant Medication,Form 27,,
Study 24,DEU,Site 880,Subject 9119,On Trial,Subject discontinued from study at this visit,End of Treatment,Form 16,29 OCT 2025,16
Study 24,DEU,Site 880,Subject 9119,On Trial,,Non-drug therapies,Form 28,,
Study 24,DEU,Site 880,Subject 9119,On Trial,Subject continuing,Screening,Form 12,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9119,On Trial,Subject continuing,Screening,Form 24,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9119,On Trial,Subject continuing,Screening,Form 8,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9119,On Trial,Subject continuing,Screening,Form 9,30 SEP 2025,45
Study 24,DEU,Site 880,Subject 9119,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 880,Subject 9119,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 880,Subject 9119,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 880,Subject 9120,On Trial,Subject continuing,Screening,Form 12,7 OCT 2025,38
Study 24,DEU,Site 880,Subject 9120,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 880,Subject 9120,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 880,Subject 9120,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 880,Subject 9123,Enrolled,Subject continuing,Screening,Form 5,27 OCT 2025,18
Study 24,DEU,Site 880,Subject 9123,Enrolled,Subject continuing,Screening,Form 29,27 OCT 2025,18
Study 24,DEU,Site 880,Subject 9124,Enrolled,Subject continuing,Screening,Form 5,27 OCT 2025,18
Study 24,DEU,Site 880,Subject 9124,Enrolled,Subject continuing,Screening,Form 29,27 OCT 2025,18
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 21,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 12,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 5,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 22,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 23,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 17,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 19,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 24,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 8,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 9,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 25,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 16,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,Subject continuing,Screening,Form 20,28 OCT 2025,17
Study 24,DEU,Site 880,Subject 9125,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 880,Subject 9125,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 880,Subject 9125,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 880,Subject 9125,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 883,Subject 9190,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,16 SEP 2025,59
Study 24,DEU,Site 883,Subject 9190,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 883,Subject 9190,On Trial,Subject continuing,Screening,Form 12,08 SEP 2025,67
Study 24,DEU,Site 883,Subject 9190,On Trial,Subject continuing,Screening,Form 16,08 SEP 2025,67
Study 24,DEU,Site 883,Subject 9190,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 883,Subject 9190,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 883,Subject 9191,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 883,Subject 9191,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,DEU,Site 883,Subject 9191,On Trial,Subject continuing,Screening,Form 16,29 SEP 2025,46
Study 24,DEU,Site 883,Subject 9191,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 883,Subject 9191,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 883,Subject 9192,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,7 OCT 2025,38
Study 24,DEU,Site 883,Subject 9192,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 883,Subject 9192,On Trial,Subject continuing,Screening,Form 12,30 SEP 2025,45
Study 24,DEU,Site 883,Subject 9192,On Trial,Subject continuing,Screening,Form 16,30 SEP 2025,45
Study 24,DEU,Site 883,Subject 9192,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 883,Subject 9192,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 887,Subject 9280,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 887,Subject 9280,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 887,Subject 9281,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 887,Subject 9281,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9287,Discontinued,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9287,Discontinued,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9288,On Trial,,Antineoplastic Therapy,Form 30,,
Study 24,DEU,Site 888,Subject 9288,On Trial,,Non-drug therapies,Form 28,,
Study 24,DEU,Site 888,Subject 9288,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9288,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9289,Screen Failure,,Adverse Event,Form 31,,
Study 24,DEU,Site 888,Subject 9290,Enrolled,Subject continuing,Screening,Form 5,07 AUG 2025,99
Study 24,DEU,Site 888,Subject 9291,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,03 SEP 2025,72
Study 24,DEU,Site 888,Subject 9291,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9291,On Trial,Subject continuing,Screening,Form 22,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9291,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9291,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9291,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 12,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 5,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 22,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 24,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 8,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 9,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,Subject continuing,Screening,Form 25,11 AUG 2025,95
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9292,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Adverse Event,Form 31,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Concomitant Medication,Form 27,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Medical History,Form 32,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Non-drug therapies,Form 28,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9293,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9294,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9294,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9294,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9294,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9295,Enrolled,Subject continuing,Screening,Form 5,18 AUG 2025,88
Study 24,DEU,Site 888,Subject 9296,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 12,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 5,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 24,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 8,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 9,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,Subject continuing,Screening,Form 25,27 AUG 2025,79
Study 24,DEU,Site 888,Subject 9296,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9296,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9296,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9296,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9296,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 888,Subject 9297,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,23 SEP 2025,52
Study 24,DEU,Site 888,Subject 9297,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9297,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9297,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9297,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9298,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,18 SEP 2025,57
Study 24,DEU,Site 888,Subject 9298,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9298,On Trial,Subject continuing,Screening,Form 26,04 SEP 2025,71
Study 24,DEU,Site 888,Subject 9298,On Trial,Subject continuing,Screening,Form 23,04 SEP 2025,71
Study 24,DEU,Site 888,Subject 9298,On Trial,Subject continuing,Screening,Form 17,04 SEP 2025,71
Study 24,DEU,Site 888,Subject 9298,On Trial,Subject continuing,Screening,Form 19,04 SEP 2025,71
Study 24,DEU,Site 888,Subject 9298,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9298,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9299,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9300,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,12 SEP 2025,63
Study 24,DEU,Site 888,Subject 9300,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9300,On Trial,Subject continuing,Screening,Form 26,02 SEP 2025,73
Study 24,DEU,Site 888,Subject 9300,On Trial,Subject continuing,Screening,Form 24,02 SEP 2025,73
Study 24,DEU,Site 888,Subject 9300,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9300,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9300,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9301,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9301,On Trial,Subject continuing,Screening,Form 22,15 SEP 2025,60
Study 24,DEU,Site 888,Subject 9301,On Trial,Subject continuing,Screening,Form 23,15 SEP 2025,60
Study 24,DEU,Site 888,Subject 9301,On Trial,Subject continuing,Screening,Form 17,15 SEP 2025,60
Study 24,DEU,Site 888,Subject 9301,On Trial,Subject continuing,Screening,Form 19,15 SEP 2025,60
Study 24,DEU,Site 888,Subject 9301,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9301,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 888,Subject 9301,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9301,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9302,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 21,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 12,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 5,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 17,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 24,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 8,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 9,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 25,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,Subject continuing,Screening,Form 16,16 SEP 2025,59
Study 24,DEU,Site 888,Subject 9302,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9302,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9302,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 888,Subject 9302,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9302,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9303,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9304,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 21,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 12,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 5,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 24,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 8,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 9,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 25,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,Subject continuing,Screening,Form 16,30 SEP 2025,45
Study 24,DEU,Site 888,Subject 9304,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9304,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9304,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Cycle 1 Day 1,Form 26,16 OCT 2025,29
Study 24,DEU,Site 888,Subject 9305,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 21,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 12,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 5,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 24,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 8,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 9,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 25,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,Subject continuing,Screening,Form 16,07 OCT 2025,38
Study 24,DEU,Site 888,Subject 9305,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9305,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9305,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9305,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,16 OCT 2025,29
Study 24,DEU,Site 888,Subject 9306,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 21,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 12,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 8,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 9,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 25,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,Subject continuing,Screening,Form 16,14 OCT 2025,31
Study 24,DEU,Site 888,Subject 9306,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9306,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9306,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9306,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9306,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 888,Subject 9307,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 12,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 5,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 24,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 8,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 9,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,Subject continuing,Screening,Form 25,17 OCT 2025,28
Study 24,DEU,Site 888,Subject 9307,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 888,Subject 9307,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 888,Subject 9307,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 888,Subject 9307,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 888,Subject 9307,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 281,Subject 2364,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 2365,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 2365,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,DEU,Site 281,Subject 9328,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 281,Subject 9329,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 9329,On Trial,Subject continuing,Screening,Form 12,6 OCT 2025,39
Study 24,DEU,Site 281,Subject 9332,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 9335,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 9335,On Trial,Subject continuing,Screening,Form 17,08 OCT 2025,37
Study 24,DEU,Site 281,Subject 9336,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 281,Subject 9339,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 2187,Subject 47737,On Trial,Subject continuing,Screening,Form 12,04 SEP 2025,71
Study 24,DEU,Site 2187,Subject 47737,On Trial,Subject continuing,Screening,Form 17,04 SEP 2025,71
Study 24,DEU,Site 2187,Subject 47739,On Trial,Subject continuing,Screening,Form 12,02 OCT 2025,43
Study 24,DEU,Site 2187,Subject 47739,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 2187,Subject 47739,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 2187,Subject 47739,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 2187,Subject 47739,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 2187,Subject 47739,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,Subject continuing,Screening,Form 21,15 OCT 2025,30
Study 24,DEU,Site 2187,Subject 47740,On Trial,Subject continuing,Screening,Form 12,15 OCT 2025,30
Study 24,DEU,Site 2187,Subject 47740,On Trial,Subject continuing,Screening,Form 16,15 OCT 2025,30
Study 24,DEU,Site 2187,Subject 47740,On Trial,Subject continuing,Screening,Form 20,15 OCT 2025,30
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 18,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 2187,Subject 47740,On Trial,,Study Treatment,Form 10,,
Study 24,DEU,Site 2187,Subject 47741,Enrolled,,Adverse Event,Form 31,,
Study 24,DEU,Site 2187,Subject 47741,Enrolled,,Concomitant Medication,Form 27,,
Study 24,DEU,Site 2187,Subject 47741,Enrolled,,Medical History,Form 32,,
Study 24,DEU,Site 904,Subject 9600,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,27 OCT 2025,18
Study 24,DEU,Site 904,Subject 9600,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 904,Subject 9600,On Trial,Subject continuing,Screening,Form 12,22 OCT 2025,23
Study 24,DEU,Site 904,Subject 9600,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 904,Subject 9600,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 904,Subject 9600,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 286,Subject 2386,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 286,Subject 2386,On Trial,Subject continuing,Screening,Form 17,23 JUL 2025,114
Study 24,DEU,Site 286,Subject 2386,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 286,Subject 2386,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 286,Subject 2388,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 286,Subject 2388,On Trial,Subject continuing,Screening,Form 19,03 SEP 2025,72
Study 24,DEU,Site 286,Subject 2388,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 286,Subject 2388,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 286,Subject 2389,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 286,Subject 2389,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 286,Subject 2389,On Trial,,Study Treatment,Form 3,,
Study 24,DEU,Site 286,Subject 2389,On Trial,,Study Treatment,Form 7,,
Study 24,DEU,Site 286,Subject 2390,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 286,Subject 2390,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 286,Subject 2390,On Trial,,Study Treatment,Form 2,,
Study 24,DEU,Site 286,Subject 9776,On Trial,,Disposition,Form 1,,
Study 24,DEU,Site 286,Subject 9776,On Trial,Subject continuing,Screening,Form 12,06 OCT 2025,39
Study 24,DEU,Site 286,Subject 9776,On Trial,Subject continuing,Screening,Form 9,06 OCT 2025,39
Study 24,DEU,Site 286,Subject 9776,On Trial,,Study Treatment,Form 6,,
Study 24,DEU,Site 286,Subject 9776,On Trial,,Study Treatment,Form 2,,
Study 24,HKG,Site 10,Subject 18,On Trial,,Antineoplastic Therapy,Form 30,,
Study 24,HKG,Site 10,Subject 852,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,20 AUG 2025,86
Study 24,HKG,Site 10,Subject 852,On Trial,Subject continuing,Screening,Form 13,28 JUL 2025,109
Study 24,HKG,Site 10,Subject 852,On Trial,Subject continuing,Screening,Form 8,28 JUL 2025,109
Study 24,HKG,Site 10,Subject 852,On Trial,Subject continuing,Screening,Form 9,28 JUL 2025,109
Study 24,HKG,Site 110,Subject 893,On Trial,,Disposition,Form 1,,
Study 24,HKG,Site 110,Subject 893,On Trial,,Study Treatment,Form 6,,
Study 24,HKG,Site 110,Subject 893,On Trial,,Study Treatment,Form 2,,
Study 24,HKG,Site 110,Subject 893,On Trial,,Study Treatment,Form 3,,
Study 24,HKG,Site 110,Subject 893,On Trial,,Study Treatment,Form 10,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Disposition,Form 1,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 18,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 3,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 7,,
Study 24,IND,Site 597,Subject 4019,On Trial,,Study Treatment,Form 10,,
Study 24,IND,Site 597,Subject 30317,On Trial,,Disposition,Form 1,,
Study 24,IND,Site 597,Subject 30317,On Trial,Subject continuing,Screening,Form 5,6 NOV 2025,8
Study 24,IND,Site 597,Subject 30317,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 597,Subject 30317,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 597,Subject 30317,On Trial,,Study Treatment,Form 3,,
Study 24,IND,Site 597,Subject 30317,On Trial,,Study Treatment,Form 10,,
Study 24,IND,Site 597,Subject 30318,On Trial,,Disposition,Form 1,,
Study 24,IND,Site 597,Subject 30318,On Trial,Subject continuing,Screening,Form 12,6 NOV 2025,8
Study 24,IND,Site 597,Subject 30318,On Trial,Subject continuing,Screening,Form 5,6 NOV 2025,8
Study 24,IND,Site 597,Subject 30318,On Trial,Subject continuing,Screening,Form 17,6 NOV 2025,8
Study 24,IND,Site 597,Subject 30318,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 597,Subject 30318,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 597,Subject 30318,On Trial,,Study Treatment,Form 3,,
Study 24,IND,Site 597,Subject 30318,On Trial,,Study Treatment,Form 10,,
Study 24,IND,Site 1646,Subject 30346,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 1646,Subject 30346,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 1646,Subject 30347,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 1646,Subject 30347,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 1646,Subject 30347,On Trial,,Study Treatment,Form 18,,
Study 24,IND,Site 2163,Subject 47571,On Trial,,Disposition,Form 1,,
Study 24,IND,Site 2163,Subject 47571,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 2163,Subject 47571,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 2163,Subject 47572,On Trial,,Disposition,Form 1,,
Study 24,IND,Site 2163,Subject 47572,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 2163,Subject 47572,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 2163,Subject 47572,On Trial,,Study Treatment,Form 18,,
Study 24,IND,Site 2163,Subject 47572,On Trial,,Study Treatment,Form 7,,
Study 24,IND,Site 1648,Subject 30396,Enrolled,Subject continuing,Screening,Form 5,03 NOV 2025,11
Study 24,IND,Site 1648,Subject 30398,On Trial,Subject continuing,Screening,Form 12,3 NOV 2025,11
Study 24,IND,Site 1648,Subject 30398,On Trial,Subject continuing,Screening,Form 5,3 NOV 2025,11
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 6,,
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 2,,
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 18,,
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 3,,
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 7,,
Study 24,IND,Site 1648,Subject 30398,On Trial,,Study Treatment,Form 10,,
Study 24,IND,Site 1648,Subject 30399,On Trial,Subject continuing,Screening,Form 5,05 NOV 2025,9
Study 24,IND,Site 1648,Subject 30399,On Trial,Subject continuing,Screening,Form 13,05 NOV 2025,9
Study 24,IND,Site 1648,Subject 30399,On Trial,Subject continuing,Screening,Form 24,05 NOV 2025,9
Study 24,ISR,Site 2188,Subject 47744,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 2188,Subject 47745,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 2188,Subject 47745,On Trial,Subject continuing,Screening,Form 17,12 AUG 2025,94
Study 24,ISR,Site 2188,Subject 47746,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,30 SEP 2025,45
Study 24,ISR,Site 2188,Subject 47746,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 524,Subject 3778,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 524,Subject 3778,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 524,Subject 3778,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 524,Subject 3778,On Trial,,Study Treatment,Form 18,,
Study 24,ISR,Site 524,Subject 3778,On Trial,,Study Treatment,Form 7,,
Study 24,ISR,Site 525,Subject 3782,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 525,Subject 3782,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 525,Subject 3782,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 525,Subject 3782,On Trial,,Study Treatment,Form 7,,
Study 24,ISR,Site 525,Subject 47748,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 525,Subject 47748,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 525,Subject 47748,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 525,Subject 47749,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 525,Subject 47749,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 525,Subject 47749,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 1791,Subject 34337,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,18 SEP 2025,57
Study 24,ISR,Site 1791,Subject 34337,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 1791,Subject 34337,On Trial,Subject continuing,Screening,Form 23,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34337,On Trial,Subject continuing,Screening,Form 17,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34337,On Trial,Subject continuing,Screening,Form 19,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34337,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 1791,Subject 34337,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 1791,Subject 34337,On Trial,,Study Treatment,Form 7,,
Study 24,ISR,Site 1791,Subject 34338,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 1791,Subject 34338,On Trial,Subject continuing,Screening,Form 12,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34338,On Trial,Subject continuing,Screening,Form 23,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34338,On Trial,Subject continuing,Screening,Form 17,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34338,On Trial,Subject continuing,Screening,Form 19,14 SEP 2025,61
Study 24,ISR,Site 1791,Subject 34338,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 1791,Subject 34338,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 1791,Subject 34339,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,17 SEP 2025,58
Study 24,ISR,Site 1791,Subject 34339,On Trial,,Disposition,Form 1,,
Study 24,ISR,Site 1791,Subject 34339,On Trial,Subject continuing,Screening,Form 23,11 SEP 2025,64
Study 24,ISR,Site 1791,Subject 34339,On Trial,Subject continuing,Screening,Form 17,11 SEP 2025,64
Study 24,ISR,Site 1791,Subject 34339,On Trial,Subject continuing,Screening,Form 19,11 SEP 2025,64
Study 24,ISR,Site 1791,Subject 34339,On Trial,,Study Treatment,Form 6,,
Study 24,ISR,Site 1791,Subject 34339,On Trial,,Study Treatment,Form 2,,
Study 24,ISR,Site 1791,Subject 34339,On Trial,,Study Treatment,Form 7,,
Study 24,KOR,Site 48,Subject 208,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 209,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 210,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 212,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 213,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 214,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 216,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 218,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 219,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 220,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 221,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 222,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 223,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 48,Subject 224,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 50,Subject 274,On Trial,Subject continuing,Screening,Form 12,3 JUL 2025,134
Study 24,KOR,Site 50,Subject 285,On Trial,Subject continuing,Screening,Form 20,11 SEP 2025,64
Study 24,KOR,Site 50,Subject 287,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 50,Subject 288,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 50,Subject 288,On Trial,Subject continuing,Screening,Form 12,17 OCT 2025,28
Study 24,KOR,Site 52,Subject 47588,On Trial,Subject continuing,Screening,Form 9,7 AUG 2025,99
Study 24,KOR,Site 52,Subject 47592,On Trial,Subject continuing,Screening,Form 22,13 AUG 2025,93
Study 24,KOR,Site 52,Subject 47596,On Trial,Subject continuing,Cycle 1 Day 15,Form 22,30 SEP 2025,45
Study 24,KOR,Site 52,Subject 47596,On Trial,Subject continuing,Screening,Form 22,26 AUG 2025,80
Study 24,KOR,Site 52,Subject 47597,On Trial,Subject continuing,Screening,Form 12,8 SEP 2025,67
Study 24,KOR,Site 52,Subject 47597,On Trial,Subject continuing,Screening,Form 22,8 SEP 2025,67
Study 24,KOR,Site 52,Subject 47600,On Trial,Subject continuing,Screening,Form 12,4 SEP 2025,71
Study 24,KOR,Site 52,Subject 47600,On Trial,Subject continuing,Screening,Form 22,4 SEP 2025,71
Study 24,KOR,Site 53,Subject 315,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 316,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 317,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 318,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 319,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 320,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 321,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 53,Subject 322,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 2165,Subject 47608,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2165,Subject 47608,On Trial,,Study Treatment,Form 18,,
Study 24,KOR,Site 2165,Subject 47608,On Trial,,Study Treatment,Form 3,,
Study 24,KOR,Site 2165,Subject 47610,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2165,Subject 47610,On Trial,,Study Treatment,Form 18,,
Study 24,KOR,Site 2165,Subject 47610,On Trial,,Study Treatment,Form 3,,
Study 24,KOR,Site 2165,Subject 47611,On Trial,,Disposition,Form 1,,
Study 24,KOR,Site 2165,Subject 47611,On Trial,,Study Treatment,Form 2,,
Study 24,KOR,Site 2165,Subject 47611,On Trial,,Study Treatment,Form 3,,
Study 24,KOR,Site 2165,Subject 47613,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2165,Subject 47613,On Trial,,Study Treatment,Form 18,,
Study 24,KOR,Site 2165,Subject 47613,On Trial,,Study Treatment,Form 3,,
Study 24,KOR,Site 2166,Subject 47616,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2166,Subject 47616,On Trial,,Study Treatment,Form 2,,
Study 24,KOR,Site 2166,Subject 47617,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2166,Subject 47617,On Trial,,Study Treatment,Form 2,,
Study 24,KOR,Site 2166,Subject 47618,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2166,Subject 47618,On Trial,,Study Treatment,Form 2,,
Study 24,KOR,Site 2166,Subject 47619,On Trial,,Study Treatment,Form 6,,
Study 24,KOR,Site 2166,Subject 47619,On Trial,,Study Treatment,Form 2,,
Study 24,KOR,Site 2169,Subject 47649,Screening,Subject discontinued from study at this visit,Screening,Form 12,29 AUG 2025,77
Study 24,KOR,Site 2169,Subject 47649,Screening,Subject discontinued from study at this visit,Screening,Form 11,29 AUG 2025,77
Study 24,KOR,Site 2169,Subject 47650,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 349,Subject 2829,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 1846,Subject 35377,Screening,Subject continuing,Screening,Form 14,30 OCT 2025,15
Study 24,PRT,Site 1846,Subject 35378,Screening,,Screening,Form 14,04 NOV 2025,10
Study 24,PRT,Site 1846,Subject 35378,Screening,,Screening,Form 15,04 NOV 2025,10
Study 24,PRT,Site 530,Subject 3799,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 530,Subject 3799,On Trial,Subject continuing,Screening,Form 5,07 OCT 2025,38
Study 24,PRT,Site 530,Subject 3799,On Trial,Subject continuing,Screening,Form 17,07 OCT 2025,38
Study 24,PRT,Site 530,Subject 3799,On Trial,,Study Treatment,Form 2,,
Study 24,PRT,Site 530,Subject 3799,On Trial,,Study Treatment,Form 3,,
Study 24,PRT,Site 530,Subject 35413,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 5,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 17,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 8,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 9,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 25,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,Subject continuing,Screening,Form 16,09 OCT 2025,36
Study 24,PRT,Site 530,Subject 35413,On Trial,,Study Treatment,Form 2,,
Study 24,PRT,Site 530,Subject 35413,On Trial,,Study Treatment,Form 3,,
Study 24,PRT,Site 530,Subject 35414,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 21,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 12,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 5,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 23,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 17,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 19,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 24,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 11,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 8,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,Subject continuing,Screening,Form 16,16 OCT 2025,29
Study 24,PRT,Site 530,Subject 35414,On Trial,,Study Treatment,Form 2,,
Study 24,PRT,Site 530,Subject 35414,On Trial,,Study Treatment,Form 3,,
Study 24,PRT,Site 530,Subject 35415,On Trial,,Disposition,Form 1,,
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 12,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 5,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 8,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 9,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 25,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,Subject continuing,Screening,Form 16,22 OCT 2025,23
Study 24,PRT,Site 530,Subject 35415,On Trial,,Study Treatment,Form 6,,
Study 24,PRT,Site 530,Subject 35415,On Trial,,Study Treatment,Form 3,,
Study 24,PRT,Site 530,Subject 35415,On Trial,,Study Treatment,Form 7,,
Study 24,PRT,Site 530,Subject 35416,Screening,Subject continuing,Screening,Form 29,31 OCT 2025,14
Study 24,PRT,Site 530,Subject 35416,Screening,Subject continuing,Screening,Form 14,31 OCT 2025,14
Study 24,TUR,Site 5,Subject 11,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 5,Subject 11,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 5,Subject 11,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 5,Subject 3566,On Trial,Subject continuing,Cycle 1 Day 1,Form 23,23 SEP 2025,52
Study 24,TUR,Site 5,Subject 3566,On Trial,Subject continuing,Cycle 1 Day 1,Form 17,23 SEP 2025,52
Study 24,TUR,Site 5,Subject 3566,On Trial,Subject continuing,Cycle 1 Day 1,Form 19,23 SEP 2025,52
Study 24,TUR,Site 5,Subject 3566,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 5,Subject 3566,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 5,Subject 3566,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 5,Subject 3566,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 21,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 12,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 5,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 22,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 13,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 23,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 17,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 19,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 8,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 9,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 25,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 16,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,Subject continuing,Screening,Form 20,02 OCT 2025,43
Study 24,TUR,Site 5,Subject 3567,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 5,Subject 3567,On Trial,,Study Treatment,Form 18,,
Study 24,TUR,Site 5,Subject 3567,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 5,Subject 3567,On Trial,,Study Treatment,Form 10,,
Study 24,TUR,Site 6,Subject 12,On Trial,Subject continuing,Cycle 2 Day 1,Form 17,04 AUG 2025,102
Study 24,TUR,Site 6,Subject 12,On Trial,Subject continuing,Cycle 3 Day 1,Form 17,09 SEP 2025,66
Study 24,TUR,Site 6,Subject 13,On Trial,Subject continuing,Cycle 3 Day 1,Form 17,10 SEP 2025,65
Study 24,TUR,Site 6,Subject 13,On Trial,Subject continuing,Cycle 4 Day 1,Form 17,10 OCT 2025,35
Study 24,TUR,Site 6,Subject 13,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 6,Subject 31074,On Trial,Subject continuing,Cycle 2 Day 1,Form 17,02 OCT 2025,43
Study 24,TUR,Site 6,Subject 31074,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2170,Subject 47651,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2170,Subject 47652,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2170,Subject 47653,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2170,Subject 47654,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2171,Subject 47655,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2171,Subject 47655,On Trial,,Study Treatment,Form 18,,
Study 24,TUR,Site 2171,Subject 47656,On Trial,Subject continuing,Cycle 4 Day 1,Form 16,22 OCT 2025,23
Study 24,TUR,Site 2171,Subject 47656,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 18,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 2171,Subject 47657,On Trial,,Study Treatment,Form 10,,
Study 24,TUR,Site 2172,Subject 47659,On Trial,,Antineoplastic Therapy,Form 30,,
Study 24,TUR,Site 2172,Subject 47659,On Trial,,Medical History,Form 32,,
Study 24,TUR,Site 2172,Subject 47659,On Trial,,Non-drug therapies,Form 28,,
Study 24,TUR,Site 2172,Subject 47660,On Trial,,Unplanned visit,Form 23,14 NOV 2025,0
Study 24,TUR,Site 2172,Subject 47660,On Trial,,Unplanned visit,Form 19,14 NOV 2025,0
Study 24,TUR,Site 2173,Subject 47667,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2174,Subject 47668,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2174,Subject 47668,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2174,Subject 47668,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2174,Subject 47668,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 2174,Subject 47669,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2174,Subject 47669,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2174,Subject 47669,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2174,Subject 47669,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,Subject continuing,Screening,Form 13,27 OCT 2025,18
Study 24,TUR,Site 2175,Subject 47670,On Trial,Subject continuing,Screening,Form 20,27 OCT 2025,18
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 18,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 7,,
Study 24,TUR,Site 2175,Subject 47670,On Trial,,Study Treatment,Form 10,,
Study 24,TUR,Site 2175,Subject 47671,Screening,Subject continuing,Screening,Form 14,05 NOV 2025,9
Study 24,TUR,Site 2176,Subject 47673,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2176,Subject 47674,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2176,Subject 47675,On Trial,,Adverse Event,Form 31,,
Study 24,TUR,Site 2176,Subject 47675,On Trial,Subject continuing,Screening,Form 21,8 SEP 2025,67
Study 24,TUR,Site 2176,Subject 47675,On Trial,Subject continuing,Screening,Form 12,8 SEP 2025,67
Study 24,TUR,Site 2176,Subject 47675,On Trial,Subject continuing,Screening,Form 22,8 SEP 2025,67
Study 24,TUR,Site 2176,Subject 47675,On Trial,Subject continuing,Screening,Form 16,8 SEP 2025,67
Study 24,TUR,Site 2176,Subject 47675,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2176,Subject 47675,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2177,Subject 47677,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2177,Subject 47678,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2177,Subject 47679,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2177,Subject 47680,Screening,,Screening,Form 14,27 OCT 2025,18
Study 24,TUR,Site 2177,Subject 47680,Screening,,Screening,Form 15,27 OCT 2025,18
Study 24,TUR,Site 2178,Subject 47681,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,05 AUG 2025,101
Study 24,TUR,Site 2178,Subject 47681,On Trial,,Non-drug therapies,Form 28,,
Study 24,TUR,Site 2178,Subject 47681,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2178,Subject 47681,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2178,Subject 47682,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,07 AUG 2025,99
Study 24,TUR,Site 2178,Subject 47682,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2178,Subject 47682,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2178,Subject 47682,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2178,Subject 47683,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,08 OCT 2025,37
Study 24,TUR,Site 2178,Subject 47683,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2178,Subject 47683,On Trial,Subject continuing,Screening,Form 16,01 OCT 2025,44
Study 24,TUR,Site 2178,Subject 47683,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2178,Subject 47683,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2179,Subject 47684,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2179,Subject 47685,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2179,Subject 47687,Screening,Subject continuing,Screening,Form 14,07 NOV 2025,7
Study 24,TUR,Site 2181,Subject 47690,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2181,Subject 47691,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2181,Subject 47692,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,04 NOV 2025,10
Study 24,TUR,Site 2181,Subject 47692,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2181,Subject 47692,On Trial,Subject continuing,Screening,Form 23,31 OCT 2025,14
Study 24,TUR,Site 2181,Subject 47692,On Trial,Subject continuing,Screening,Form 17,31 OCT 2025,14
Study 24,TUR,Site 2181,Subject 47692,On Trial,Subject continuing,Screening,Form 19,31 OCT 2025,14
Study 24,TUR,Site 2181,Subject 47692,On Trial,,Study Treatment,Form 6,,
Study 24,TUR,Site 2181,Subject 47692,On Trial,,Study Treatment,Form 2,,
Study 24,TUR,Site 2181,Subject 47692,On Trial,,Study Treatment,Form 3,,
Study 24,TUR,Site 2181,Subject 47692,On Trial,,Study Treatment,Form 10,,
Study 24,TUR,Site 558,Subject 3890,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2182,Subject 47693,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2182,Subject 47694,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2182,Subject 47695,On Trial,,Disposition,Form 1,,
Study 24,TUR,Site 2182,Subject 47695,On Trial,Subject continuing,Screening,Form 17,13 OCT 2025,32
Study 24,TWN,Site 1673,Subject 30791,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 469,Subject 3565,Enrolled,Subject continuing,Screening,Form 11,27 OCT 2025,18
Study 24,TWN,Site 469,Subject 4744,Enrolled,Subject continuing,Screening,Form 11,28 OCT 2025,17
Study 24,TWN,Site 1674,Subject 30856,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30857,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30859,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30860,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30861,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30862,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30863,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30864,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1674,Subject 30864,On Trial,Subject continuing,Screening,Form 11,12 SEP 2025,63
Study 24,TWN,Site 1675,Subject 30871,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1675,Subject 30873,On Trial,,Disposition,Form 1,,
Study 24,TWN,Site 1675,Subject 30874,On Trial,Subject continuing,Screening,Form 12,8 OCT 2025,37
Study 24,TWN,Site 1675,Subject 30874,On Trial,Subject continuing,Screening,Form 13,8 OCT 2025,37
Study 24,TWN,Site 1675,Subject 30874,On Trial,Subject continuing,Screening,Form 20,8 OCT 2025,37
Study 24,TWN,Site 1675,Subject 30874,On Trial,,Study Treatment,Form 7,,
Study 24,TWN,Site 1675,Subject 30875,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1018,Subject 14934,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 1018,Subject 14934,On Trial,,Study Treatment,Form 10,,
Study 24,USA,Site 1018,Subject 14935,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 1018,Subject 14935,On Trial,,Study Treatment,Form 10,,
Study 24,USA,Site 178,Subject 1600,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 178,Subject 1600,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 178,Subject 1600,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 178,Subject 3393,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 178,Subject 3393,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 178,Subject 3393,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 178,Subject 3394,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 178,Subject 3394,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 178,Subject 3394,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 178,Subject 3394,On Trial,,Study Treatment,Form 18,,
Study 24,USA,Site 178,Subject 40402,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 178,Subject 40402,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 178,Subject 40402,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 178,Subject 40402,On Trial,,Study Treatment,Form 18,,
Study 24,USA,Site 178,Subject 40403,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 178,Subject 40403,On Trial,Subject continuing,Screening,Form 17,30 OCT 2025,15
Study 24,USA,Site 178,Subject 40403,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 178,Subject 40403,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 178,Subject 40403,On Trial,,Study Treatment,Form 18,,
Study 24,USA,Site 178,Subject 40403,On Trial,,Study Treatment,Form 7,,
Study 24,USA,Site 326,Subject 2652,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 326,Subject 2652,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 326,Subject 2652,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 326,Subject 2652,On Trial,,Study Treatment,Form 7,,
Study 24,USA,Site 326,Subject 2654,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 326,Subject 2654,On Trial,Subject continuing,Screening,Form 12,09 SEP 2025,66
Study 24,USA,Site 326,Subject 2654,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 326,Subject 2654,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 327,Subject 2664,On Trial,Subject continuing,Cycle 5 Day 1,Form 17,17 SEP 2025,58
Study 24,USA,Site 536,Subject 3821,Screen Failure,Subject continuing,Screening,Form 12,30 JUL 2025,107
Study 24,USA,Site 536,Subject 3822,Discontinued,Subject continuing,Cycle 1 Day 1,Form 16,05 SEP 2025,70
Study 24,USA,Site 536,Subject 3822,Discontinued,Subject continuing,Screening,Form 12,08 AUG 2025,98
Study 24,USA,Site 536,Subject 3822,Discontinued,,Study Treatment,Form 2,,
Study 24,USA,Site 536,Subject 3822,Discontinued,,Study Treatment,Form 3,,
Study 24,USA,Site 536,Subject 3823,On Trial,Subject continuing,Cycle 1 Day 1,Form 16,18 SEP 2025,57
Study 24,USA,Site 536,Subject 3823,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 536,Subject 3823,On Trial,Subject continuing,Screening,Form 12,08 SEP 2025,67
Study 24,USA,Site 536,Subject 3823,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 536,Subject 3823,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 536,Subject 3823,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 536,Subject 3823,On Trial,,Study Treatment,Form 7,,
Study 24,USA,Site 536,Subject 40721,Screening,Subject continuing,Screening,Form 29,05 NOV 2025,9
Study 24,USA,Site 536,Subject 40721,Screening,Subject continuing,Screening,Form 14,05 NOV 2025,9
Study 24,USA,Site 536,Subject 40722,Screen Failure,Subject discontinued from study at this visit,Screening,Form 29,06 NOV 2025,8
Study 24,USA,Site 338,Subject 2749,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 338,Subject 2749,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 338,Subject 2749,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 338,Subject 2749,On Trial,,Study Treatment,Form 18,,
Study 24,USA,Site 1034,Subject 15652,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1034,Subject 15654,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1034,Subject 15656,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1034,Subject 15656,On Trial,Subject continuing,Screening,Form 12,18 AUG 2025,88
Study 24,USA,Site 1034,Subject 15657,On Trial,,Non-drug therapies,Form 28,,
Study 24,USA,Site 1034,Subject 15658,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41301,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41302,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41303,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41303,On Trial,Subject continuing,Screening,Form 12,29 SEP 2025,46
Study 24,USA,Site 2015,Subject 41304,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41304,On Trial,Subject continuing,Screening,Form 5,02 OCT 2025,43
Study 24,USA,Site 2015,Subject 41304,On Trial,Subject continuing,Screening,Form 8,02 OCT 2025,43
Study 24,USA,Site 2015,Subject 41304,On Trial,Subject continuing,Screening,Form 9,02 OCT 2025,43
Study 24,USA,Site 2015,Subject 41304,On Trial,Subject continuing,Screening,Form 25,02 OCT 2025,43
Study 24,USA,Site 2015,Subject 41305,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2015,Subject 41305,On Trial,Subject continuing,Screening,Form 5,22 OCT 2025,23
Study 24,USA,Site 2015,Subject 41305,On Trial,Subject continuing,Screening,Form 8,22 OCT 2025,23
Study 24,USA,Site 2015,Subject 41305,On Trial,Subject continuing,Screening,Form 9,22 OCT 2025,23
Study 24,USA,Site 2015,Subject 41305,On Trial,Subject continuing,Screening,Form 25,22 OCT 2025,23
Study 24,USA,Site 1037,Subject 15713,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1037,Subject 15713,On Trial,Subject continuing,Screening,Form 22,14 OCT 2025,31
Study 24,USA,Site 1037,Subject 15713,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 1037,Subject 15713,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 1042,Subject 15782,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 21,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 12,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 22,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 8,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 9,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 25,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,Subject continuing,Screening,Form 16,06 OCT 2025,39
Study 24,USA,Site 1042,Subject 15782,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 1042,Subject 15782,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 1042,Subject 15782,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 1042,Subject 15782,On Trial,,Study Treatment,Form 10,,
Study 24,USA,Site 2030,Subject 41801,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 2030,Subject 41801,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 2030,Subject 41802,On Trial,Subject continuing,Screening,Form 12,16 JUL 2025,121
Study 24,USA,Site 2030,Subject 41802,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 2030,Subject 41802,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 2030,Subject 41803,On Trial,,Antineoplastic Therapy,Form 30,,
Study 24,USA,Site 2030,Subject 41803,On Trial,,Non-drug therapies,Form 28,,
Study 24,USA,Site 2030,Subject 41803,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 2030,Subject 41803,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 2030,Subject 41803,On Trial,,Study Treatment,Form 18,,
Study 24,USA,Site 2030,Subject 41804,On Trial,,Study Treatment,Form 2,,
Study 24,USA,Site 2030,Subject 41804,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 2030,Subject 41805,On Trial,,Disposition,Form 1,,
Study 24,USA,Site 2030,Subject 41805,On Trial,Subject continuing,Screening,Form 22,12 AUG 2025,94
Study 24,USA,Site 2030,Subject 41805,On Trial,Subject continuing,Screening,Form 23,12 AUG 2025,94
Study 24,USA,Site 2030,Subject 41805,On Trial,Subject continuing,Screening,Form 19,12 AUG 2025,94
Study 24,USA,Site 2030,Subject 41805,On Trial,,Study Treatment,Form 6,,
Study 24,USA,Site 2030,Subject 41805,On Trial,,Study Treatment,Form 3,,
Study 24,USA,Site 2030,Subject 41807,Screening,Subject continuing,Screening,Form 33,10 OCT 2025,35
Study 24,USA,Site 2030,Subject 41808,Screening,Subject continuing,Screening,Form 14,5 NOV 2025,9
